Gilbert & Cook, Inc. Vertex Pharmaceuticals Inc Transaction History

Gilbert & Cook, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $122,623 - $137,244	-390 Reduced 33.22%	784 $275,000
Q1 2023 May 05, 2023	BUY	$283.23 - $323.1 $74,206 - $84,652	262 Added 28.73%	1,174 $369,000
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $2,000 - $2,250	7 Added 0.77%	912 $263,000
Q3 2022 Nov 03, 2022	BUY	$273.83 - $305.53 $247,816 - $276,504	905 New	905 $281,000
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $225,640 - $300,938	-1,090 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $10,992 - $13,033	43 Added 4.11%	1,090 $297,000
Q2 2020 Aug 05, 2020	SELL	$225.48 - $295.8 $9,921 - $13,015	-44 Reduced 4.03%	1,047 $304,000
Q1 2020 May 05, 2020	BUY	$199.77 - $247.81 $5,593 - $6,938	28 Added 2.63%	1,091 $260,000
Q4 2019 Feb 03, 2020	BUY	$166.71 - $223.91 $177,212 - $238,016	1,063 New	1,063 $233,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gilbert & Cook, Inc., based on Form 13F filings with the SEC.

Stay updated on Gilbert & Cook, Inc. with notifications on news.